Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease

This study has been completed.
Information provided by:
FDA Office of Orphan Products Development Identifier:
First received: April 10, 2001
Last updated: March 24, 2015
Last verified: April 2001
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2004
  Estimated Primary Completion Date: No date given